| Pharmaceutical active ingredients: |
| Erythromycin Ethylsuccinate |
| Available forms, composition and doses of Erythrocin Neo: |
| Tablets, Film-Coated; Oral; Erythromycin Ethylsuccinate 500 mg |
| Erythrocin Neo medical category: |
| Human:Acne treatment preparationsAntibacterialsErythromycinsEye anti-infectives and antisepticsMacrolidesTopical antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01FA01 - ErythromycinS01AA17 - Erythromycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Abbott |
| Related documents and information about Erythrocin Neo: |
| Erythrocin prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Erythro Ethyl | Erythromycin Ethylsuccinate | Drug Houses of Australia; U.S. Summit |
| Erythro-Basan | Erythromycin Ethylsuccinate | Sagitta Arzneimittel |
| Erythrocin Dulcet | Erythromycin Ethylsuccinate | Abbott |
| Erythrocin EES | Erythromycin Ethylsuccinate | Abbott |
| Erythrocin ES | Erythromycin Ethylsuccinate | Abbott; Pro Concepta Zug |
| Erythro-ES | Erythromycin Ethylsuccinate | Pro Doc; AA Pharma |
| Erythroforte | Erythromycin Ethylsuccinate | Abbott |
| Erythrogram | Erythromycin Ethylsuccinate | Pharma 2000 Laboratoires |
| Erythrol | Erythromycin Ethylsuccinate | Vitamed Pharmaceutical Industries |
| Erythrolar | Erythromycin Ethylsuccinate | Novartis; Lark Laboratories |